Get started
Author

R. Bernstein Molho

Observed names: Molho, Rinat Bernstein, R. Bernstein-Molcho, Rinat Bernstein Molho, Rinat Bernstein-Molho
OpenAlex ID: A5016190907
A phase-II study evaluatin safety and efficacy with weekly paclitaxel and carboplatin as a primary treatment for patients with advanced epithelial ovarian cancer (EOC)
2006 · T. Safra, R. Bernstein Molho, et al. · Journal of Clinical Oncology · 3
Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study
2026 · Carlotta Becherini, Eva Blondeaux, et al. · Radiotherapy and Oncology · 2
PDF
Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study
2024 · Matteo Lambertini, Eva Blondeaux, et al. · Obstetrical & Gynecological Survey · 2
Effect of zoledronic acid on bone loss in postmenopausal women with early breast cancer treated with sequential tamoxifen and letrozole
2009 · T. Safra, R. Bernstein Molho, et al. · Journal of Clinical Oncology · 2
330P Association of type of chemotherapy with survival outcomes in young BRCA1/2 carriers with HER2-negative early breast cancer: A secondary analysis of the BRCA BCY collaboration
2025 · R. Bernstein Molho, E. Blondeaux, et al. · Annals of Oncology · 1
Abstract GS1-08: Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: results from an international cohort study
2025 · Matteo Lambertini, Amir Sonnenblick, et al. · Clinical Cancer Research · 1
Abstract PD4-07: Association between age at diagnosis and survival among young BRCA carriers with breast cancer: results from an international multicenter hospital-based cohort study
2026 · E. Blondeaux, A. Meacci, et al. · Clinical Cancer Research
Abstract PD12-01: Surgical management of young BRCA1/2 carriers with early onset breast cancer
2026 · S. M. Wong, E. Blondeaux, et al. · Clinical Cancer Research
Additional file 2 of Managing healthcare for female BRCA carriers in the population screening era: developing a harmonized national policy for surveillance and risk-reduction
2026 · Michaelson-Cohen, Rachel, Armon, Shunit, et al. · Figshare
Additional file 1 of Managing healthcare for female BRCA carriers in the population screening era: developing a harmonized national policy for surveillance and risk-reduction
2026 · Michaelson-Cohen, Rachel, Armon, Shunit, et al. · Figshare
Managing healthcare for female BRCA carriers in the population screening era: developing a harmonized national policy for surveillance and risk-reduction
2026 · Michaelson-Cohen, Rachel, Armon, Shunit, et al. · Figshare
268P Association between baseline body mass index and survival outcomes in BRCA carriers with breast cancer diagnosed at a young age: Results from an International cohort study
2025 · F. Poggio, C. Molinelli, et al. · ESMO Open
PDF
154P Characteristics and outcomes of young BRCA carriers with triple-negative breast cancer (TNBC) according to histology subtype
2025 · F. Giugliano, M. Bruzzone, et al. · ESMO Open
Abstract P2-09-16: Clinicopatological features and outcome of breast cancer in CHEK2 germline mutation carriers
2022 · Shir Schlosser, Rinat Bernstein Molho, et al. · Cancer Research
Abstract P5-08-10: Surveillance for BRCA1/2 mutation carriers - Is "early detection" really early enough?
2020 · Rinat Bernstein Molho, Bella Kaufman, et al. · Cancer Research
Assessment of breast cancer risk in BRCA carriers with ovarian cancer: Evaluation of data from longitudinal observation.
2019 · Tamar Safra, Barliz Waissengrin, et al. · Journal of Clinical Oncology
Preventive bilateral mastectomy (PBS) in BRCA mutation carriers with ovarian cancer: Is it justified?
2019 · T. Safra, B. Waissengrin, et al. · Annals of Oncology
0159 Zoledronic acid protective effect on bone loss in postmenopausal women with early breast cancer switched from tamoxifen to letrozole
2009 · T. Safra, R. Bernstein Molho, et al. · The Breast
PDF
Activity and toxicity of docetaxel plus capecitabine in a pilot study in ovarian cancer
2008 · T. Safra, R. Bernstein-Molcho, et al. · Journal of Clinical Oncology
Weekly Topotecan In The Treatment Of Relapsed And Persistent Ovarian Cancer
2006 · T. Safra, R. Bernstein Molho, et al. · International Journal of Gynecological Cancer
Weekly Paclitaxel And Carboplatin As Primary Treatment For Patients With Advanced Epithelial Ovarian Cancer (Eoc) - A Phase Ii Study
2006 · T. Safra, R. Bernstein Molho, et al. · International Journal of Gynecological Cancer
Works count: 21
Citation count: 11
H-index: 2
I10-index:
Year
Topic
Type